Aarhus N

• STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease Not authorised
  2022-500816-21-00 6 Acute Exacerbation of Chronic Obstructive Pulmonary Disease
• A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu … Not authorised
  2022-502781-24-00 11 ASCVD - Atherosclerotic Cardiovascular Disease
• Phase 1b/2a Study to Evaluate Alnuctamab in Combination with Mezigdomide in Relapsed and/or Refractory Multiple Myeloma. Not authorised
  2023-504367-16-00 4 Relapsed and/or Refractory Multiple Myeloma
• An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Not authorised
  2023-508444-22-00 1 Chronic hepatitis B infection
• The effect of suprainguinal fascia iliaca compartment block Not authorised
  2023-510388-37-00 4 Hip Pain
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sa … Pending
  2023-507590-18-00 4 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• Route of nutrition and muscle wasting after oesophagectomy Pending
  2023-507649-27-00 6 Oesophagectomy
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• Allogeneic adipose tissue-derived Mesenchymal stromal cells for the treatment of chronic-active antibody mediated rejection in Kidney transp … Pending
  2024-510723-18-00 7 Chronic active antibody mediated rejection
• Extension Study of ACT-EARLY Pending
  2024-513676-18-00 5 Transthyretin Amyloidosis
• ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa … Pending
  2024-513778-23-00 5 Colon and rectal cancer tumor stage II-III, tumor with somatic alterat
• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent … Pending
  2024-516723-14-00 6 Rheumatoid Arthritis
• Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending
  2024-517133-40-00 5 newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC ampli
• Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe … Pending
  2024-518420-80-00 5 Primary infection prophylaxis for secondary immunodeficiency (SID) in
• TRALULALA-AZI Pending
  2024-518730-88-00 6 Chronic Atelectasis
• The SGL-TX-PTDM study Pending
  2024-518774-14-00 4 Kidney transplant recipients
• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending
  2024-518821-13-00 4 Non-cystic Fibrosis Bronchiectasis
• Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN) Pending
  2024-520042-31-00 6 HSV-2 meningitis
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending
  2024-520218-23-00 10 Pulmonary Arterial Hypertension
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• Comparison of Desmopressin (Minirin vs. Sandoz) in Children with Bedwetting. Pending
  2025-521256-29-00 6 Nocturnal enuresis
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending
  2025-521590-13-00 5 Moderately to Severely Active Crohn’s Disease
• A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indicat … Pending
  2025-522362-78-00 6 severely active ulcerative colitis (US) and CD (Crohn’s disease)

Showing 1–24 of 582 trials